Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ирина Николаевна Бескаравайная, Ирина Сергеевна СтебловскаяfiledCriticalИрина Николаевна Бескаравайная
Priority to UAU201314607UpriorityCriticalpatent/UA90070U/en
Publication of UA90070UpublicationCriticalpatent/UA90070U/en
Medicines That Contain Protein Lipid Enzymes And Other Medicines
(AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
A method for preventing macular edema following phacoemulsification of the cataract comprises the use of anti-inflammatory and antiedematic agents. For anti-excudative effect, L-lysine escinate 0.1 % is administered intravenously in a bolus mode.
UAU201314607U2013-12-132013-12-13Method for preventing macular edema following phacoemulsification of cataract
UA90070U
(en)
Anti-drosophila antibody conjugates similar to delta 3 (anti-dll3) and medications for use in the treatment of melanoma. (divisional application 201602105)